Top compounds associated with response to ANXA11


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.7
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.017 0.7
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.037 0.7
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.018 0.7
mRNA XMD8-85 GDSC1000 pan-cancer AAC 0.026 0.7
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.025 0.7
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.017 0.7
mRNA VNLG/124 GDSC1000 pan-cancer AAC 0.015 0.7
Download CSV